cagrilintide semaglutide cagrisema phase 3 results 2024 2025 Cagrilintide–semaglutide (CagriSema) versus or in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, study Novo Nordisk's CagriSema trial deals
Description
Fair editorial context for readers

An India Today investigation into lax enforcement of drug norms that make accessing prescription-only medicines easy, and rising misuse of #weightloss drugs in the country #Mounjaro #Wegovy #Ozempic Elilill Pharma Novo Nordisk
5 targeted probiotic strains, including Akkermansia

How much weight can I lose with Wegovy